PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
4.390
0.00 (0.00%)
At close: Apr 2, 2026, 4:00 PM EDT
4.362
-0.028 (-0.64%)
After-hours: Apr 2, 2026, 4:51 PM EDT
PolyPid Employees
As of December 31, 2025, PolyPid had 75 total employees, including 69 full-time and 6 part-time employees. The number of employees increased by 14 or 22.95% compared to the previous year.
Employees
75
Change (1Y)
14
Growth (1Y)
22.95%
Revenue / Employee
n/a
Profits / Employee
-$468,068
Market Cap
83.78M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 75 | 14 | 22.95% | 69 | 6 |
| Dec 31, 2024 | 61 | -1 | -1.61% | 57 | 4 |
| Dec 31, 2023 | 62 | 2 | 3.33% | 59 | 3 |
| Dec 31, 2022 | 60 | -19 | -24.05% | 57 | 3 |
| Dec 31, 2021 | 79 | 10 | 14.49% | 75 | 4 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Gossamer Bio | 162 |
| Fortress Biotech | 101 |
| Seres Therapeutics | 66 |
| aTyr Pharma | 60 |
| Vivani Medical | 37 |
| Cognition Therapeutics | 28 |
| Gain Therapeutics | 25 |
| NeurAxis | 21 |
PYPD News
- 2 days ago - PolyPid Initiates D-PLEX₁₀₀ NDA Submission to the FDA - GlobeNewsWire
- 16 days ago - PolyPid Receives PDUFA Fee Waiver from FDA for D-PLEX₁₀₀'s New Drug Application - GlobeNewsWire
- 5 weeks ago - PolyPid Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - PolyPid Ltd. (PYPD) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results - GlobeNewsWire
- 2 months ago - PolyPid to Report Fourth Quarter 2025 Financial Results and Operational Highlights on February 11, 2026 - GlobeNewsWire
- 3 months ago - PolyPid Appoints Veteran MedTech Leader Brooke Story as Chairman of the Board of Directors - GlobeNewsWire
- 4 months ago - PolyPid Ltd. (PYPD) Discusses the Science and Business Case for D-PLEX100 in Tackling Surgical Site Infections Transcript - Seeking Alpha